title: Bioresorbable vascular scaffolds: From patient selection to optimal scaffold implantation; tips and tricks to minimize device failure.
abstract: Bioresorbable vascular scaffolds (BVS) have become an attractive option in the field of percutaneous coronary intervention due to the complete resorption process that occurs over a few years. On the other hand, current generation devices have several limitations when compared to metallic drug-eluting stents including bulky struts and relatively less radial strength, and it has been indicated that an optimized implantation strategy is required. In this article, various tips and tricks to optimize implantation of current generation BVS are discussed. © 2016 Wiley Periodicals, Inc.
authors: Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy.|Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy.
authors: Akihito
authors: A
authors: Tanaka
authors: Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy.|Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy.|Imperial College London, United Kingdom.
authors: Richard J
authors: RJ
authors: Jabbour
authors: Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy.|Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy.
authors: Azeem
authors: A
authors: Latib
authors: Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy. info@emocolumbus.it.|Interventional Cardiology Unit, San Raffaele Scientific Institute, Milan, Italy. info@emocolumbus.it.
authors: Antonio
authors: A
authors: Colombo
mesh_terms: D020341:Absorbable Implants; D003324:Coronary Artery Disease / Q000601:surgery*; D054855:Drug-Eluting Stents; D006801:Humans; D018579:Patient Selection; D062645:Percutaneous Coronary Intervention / Q000379:methods*; D017410:Practice Guidelines as Topic; D011475:Prosthesis Failure; D054457:Tissue Scaffolds
keywords: bioresorbable scaffold; coronary disease; percutaneous coronary intervention